000 01249 a2200337 4500
005 20250514181007.0
264 0 _c20040712
008 200407s 0 0 eng d
022 _a0897-5957
024 7 _a10.1111/j.1527-3466.2004.tb00130.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSaini, Harjot K
245 0 0 _aTherapeutic potentials of sarpogrelate in cardiovascular disease.
_h[electronic resource]
260 _bCardiovascular drug reviews
_c2004
300 _a27-54 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aCardiovascular Diseases
_xdrug therapy
650 0 4 _aFibrinolytic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aSerotonin 5-HT2 Receptor Antagonists
650 0 4 _aSuccinates
_xtherapeutic use
700 1 _aTakeda, Nobuakira
700 1 _aGoyal, Ramesh K
700 1 _aKumamoto, Hideo
700 1 _aArneja, Amarjit S
700 1 _aDhalla, Naranjan S
773 0 _tCardiovascular drug reviews
_gvol. 22
_gno. 1
_gp. 27-54
856 4 0 _uhttps://doi.org/10.1111/j.1527-3466.2004.tb00130.x
_zAvailable from publisher's website
999 _c14699991
_d14699991